Changes to Board

S-Ventures PLC
18 January 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION, AS PERMITTED BY UK MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

S-Ventures PLC

("S-Ventures" or the "Company" or the "Group")

Changes to Board

S-Ventures (AQSE: SVEN), the company investing in brands across the natural, wellness and food-tech categories, announces that David Mitchell has stepped down from the Board following 3 years as Chairman.  David has successfully navigated and supported S-Ventures through its growth journey and played a significant part in executing and overseeing several significant transactions. The Company wishes David the best and thanks him for his work over the last 3 years. The business continues to develop and whilst there have been challenges, David has always been a valued source of strategic input and advice.

 

Current Non-Executive Director, Robert Hewitt, will assume the position of Chairman on an interim basis.

 

S-Ventures continues to explore funding alternatives in what remains a fragile capital markets environment and is pleased to report that group profitability on an EBITDA basis remains positive.

 

For further information, please contact:

 

S-Ventures plc

Scott Livingston (Chief Executive Officer)

+44 (0) 203 475 0230

Stephen Argent (Chief Financial Officer)





VSA Capital, AQSE Corporate Adviser and Broker:

Andrew Raca

Matt Harker

 

   +44 (0) 20 3005 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100